This was investigated using mRNA results from peripheral blood, which showed that ZBTB4 mRNA expression was remarkably reduced in the peripheral blood of pancreatic cancer patients relative to that in healthy individuals (Fig. 6A). Here, ZBTB4 is linked to familial pancreatic carcinoma.